HCA Healthcare
$423.39Change from previous close: −0.79%Absolute change: −$3.35
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- $93.92B
- Enterprise value
- $145.52B
- P/E (trailing 12 months)
- 14.3
- Forward P/E
- 13.2
- PEG
- 1.31
- Price/sales
- 1.20
- EV/EBITDA
- 9.24
- EV/revenue
- 1.87
Profitability and growth
- Gross margin
- 42.6%
- Operating margin
- 15.2%
- Net margin
- 8.8%
- ROA
- 12.3%
- Revenue growth (year over year)
- 8.7%
- Earnings growth (year over year)
- 11.6%
Financial health
- Total cash
- $1.13B
- Total debt
- $51.55B
- Current ratio
- 0.99
- Quick ratio
- 0.78
Dividends
- Annual dividend per share
- $3.12
- Dividend yield
- 0.7%
- Payout ratio
- 10.1%
- Ex-dividend date
- September 16, 2026
Analysts and estimates
- Average price target
- $454.23
- Median price target
- $450.00
- High price target
- $579.00
- Low price target
- $380.00
- Analysts with a price target
- 22
- Consensus
- Buy
- Forward EPS
- $32.02
- EPS estimate, current year
- $29.49
Shares and trading
- Beta
- 1.11
- Average volume
- 1.5M
- Shares outstanding
- 221.84M
- Float
- 144.31M
- Institutional ownership
- 78.9%
- Insider ownership
- 16.6%
- Short interest (% of float)
- 4.6%
- Short ratio (days)
- 4.85